WSB1: from homeostasis to hypoxia.

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• The WSB1 gene is crucial in development and cancer, with complex transcriptional regulation producing multiple functional transcripts.
• The primary WSB1 protein isoform acts as a substrate recognition component of an E3 ubiquitin ligase, mediating protein ubiquitylation and degradation.
• Emerging research highlights WSB1's role in neuroprotection, particularly in Parkinson's Disease by modifying neurotoxic proteins like LRRK2.

Purpose of the Study:

• To elucidate the multifaceted roles of WSB1 in cellular processes, including neuroprotection, metabolism, and cancer.
• To investigate WSB1's function as a regulator of protein degradation in response to hypoxia.
• To explore WSB1's potential as an oncogene and its involvement in the Warburg effect.

Main Methods:

• Analysis of WSB1 gene regulation and protein function.
• Investigation of WSB1's role in protein ubiquitylation and degradation pathways.
• Studies on WSB1's involvement in hypoxia response, glucose metabolism, and neurodegenerative disease models.

Main Results:

• WSB1 regulates the degradation of proteins like HIPK2, RhoGDI2, and VHL, impacting hypoxia response and apoptosis.
• WSB1 protects HIF-1 function by degrading VHL and reduces apoptosis by degrading HIPK2.
• WSB1 is implicated in glucose metabolism, potentially mediating the Warburg effect in cancer cells by maintaining HIF1 function.

Conclusions:

• WSB1 plays significant roles in cellular metabolism, hypoxia response, and neuroprotection, with implications for cancer development and progression.
• Dysregulation of WSB1 in cancer specimens suggests its biological relevance in oncogenesis.
• WSB1's dual role as a potential oncogene and neuroprotective agent warrants further investigation, aided by new inducible expression systems.